Go Pro
OTCMKTS:IGXT

IntelGenx Technologies (IGXT) Stock Price, News & Analysis

IntelGenx Technologies logo
$0.17 0.00 (0.00%)
As of 09/25/2026

About IntelGenx Technologies Stock (OTCMKTS:IGXT)

Advanced

Key Stats

Today's Range
$0.17
▼
$0.17
50-Day Range
$0.17
▼
$0.17
52-Week Range
$0.09
▼
$0.22
Volume
N/A
Average Volume
N/A
Market Capitalization
$29.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

IntelGenx Technologies Corp. is a pharmaceutical company focused on developing and commercializing novel drug-delivery products. Based in Montreal, Quebec, the company specializes in oral thin-film technologies designed to deliver active pharmaceutical ingredients through films that dissolve in the mouth.

Its proprietary VersaFilm platform is intended to support a range of formulations, including immediate-release and extended-release products. IntelGenx develops prescription and over-the-counter medicines, as well as products for pharmaceutical partners, and may provide formulation development, manufacturing, and related commercialization services.

The company’s portfolio and development activities have included oral films for conditions such as migraine and other therapeutic applications. IntelGenx works with partners in North America and other international markets to advance its drug-delivery products. Its business is centered on applying film-based delivery technology to improve convenience, dosing, and patient administration.

AI Generated. May Contain Errors.

Receive IGXT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IntelGenx Technologies and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IGXT Stock News Headlines

First Look: Elon’s “Starphone”
Rumors are swirling that Elon Musk is developing a new mobile device that could rival the iPhone. It's said to be thinner, longer-lasting on battery, and cheaper to produce, with the ability to work worldwide without relying on cell towers. Former Bloomberg reporter and SAC Capital trader Josh Baylin says the evidence is mounting. He notes the FCC recently gave Musk a green light connected to his mobile plans, adding fuel to speculation. Baylin previously called the smartphone boom in 2004 and predicted Apple would sell a billion phones when others expected a fraction of that.tc pixel
See More Headlines

IGXT Stock Analysis - Frequently Asked Questions

IntelGenx Technologies' stock was trading at $0.1670 at the beginning of the year. Since then, IGXT stock has increased by 0.0% and is now trading at $0.1670.

IntelGenx Technologies Corp. (OTCMKTS:IGXT) posted its quarterly earnings results on Thursday, November, 12th. The company reported ($0.01) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.02) by $0.01. The company earned $0.51 million during the quarter.

Shares of IGXT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that IntelGenx Technologies investors own include Pfizer (PFE), Tesla (TSLA), Advanced Micro Devices (AMD), Ford Motor (F), Rithm Capital (RITM), Rolls-Royce Holdings PLC (RYCEY) and Blink Charging (BLNK).

Company Calendar

Last Earnings
11/12/2020
Today
9/28/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:IGXT
CIK
1098880
Employees
38
Year Founded
2003

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$1.04 million
Price / Sales
28.05
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.07) per share
Price / Book
-2.39

Miscellaneous

Outstanding Shares
174,658,000
Free Float
101,214,000
Market Cap
$29.17 million
Optionable
Not Optionable
Beta
2.47

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (OTCMKTS:IGXT) was last updated on 9/28/2026 by MarketBeat.com Staff.
From Our Partners